Sequence types and plasmid carriage of uropathogenic Escherichia coli devoid of phenotypically detectable resistance

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 1, 2012, Pages 69-73

  Bengtsson, Stina ^a   Naseer, Umaer ^b   Sundsfjord, Arnfinn ^b,c   Kahlmeter, Gunnar ^a,d   Sundqvist, Martin ^a,d  

^a CENTRAL HOSPITAL   (Sweden)

^b UNIVERSITY OF TROMSØ   (Norway)

^c UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

MLST; Replicons; UTIs; Wild type

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; CEFEPIME; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CEFTIBUTEN; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; FOSFOMYCIN TROMETAMOL; GENTAMICIN; IMIPENEM; KANAMYCIN; MECILLINAM; MEROPENEM; NALIDIXIC ACID; NEOMYCIN; NITROFURANTOIN; NUCLEASE S1; STREPTOMYCIN; TETRACYCLINE; TOBRAMYCIN; TRIMETHOPRIM; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHENOTYPE; PHYLOGENY; PLASMID; POLYMERASE CHAIN REACTION; REPLICON; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI; CLASSIFICATION; DRUG EFFECT; ESCHERICHIA COLI INFECTION; EUROPE; GENETICS; GENOTYPE; HUMAN; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; ESCHERICHIA COLI INFECTIONS; EUROPE; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; PLASMIDS; POLYMERASE CHAIN REACTION; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI;

EID: 84859173262     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr421     Document Type: Article

References (25)

1. Johnson TJ, Wannemuehler YM, Johnson SJ et al. Plasmid replicon typing of commensal and pathogenic Escherichia coli isolates. Appl Environ Microbiol 2007; 73: 1976-83.
2. Martinez JL, Baquero F. Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity and antibiotic resistance.Clin Microbiol Rev 2002; 15: 647-79.
3. Maiden MC, Bygraves JA, Feil E et al. Multilocus sequence typing:a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci USA 1998; 95:3140-5.
4. Wirth T, Flaush D, Lan R et al. Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol 2006; 60: 1136-51.
5. Tartof S, Solberg O, Manges A et al. Analysis of a uropathogenic Escherichia coli clonal group by multilocus sequence typing. J Clin Microbiol 2005;43: 5860-4.
6. Olesen B, Scheutz F, Menard M et al. Three-decade epidemiological analysis of Escherichia coli O15:K52:H1. J Clin Microbiol 2009; 47:1857-62.
7. Naseer U, Haldorsen B, Tofteland S et al. Molecular characterization of CTX-M-15-producing clinical isolates of Escherichia coli reveals the spread of multidrug-resistant ST131(O25:H4) and ST964(O102:H6) strains in Norway. APMIS 2009; 117: 526-36.
8. Johnson JR, Menard M, Johnston B et al. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob Agents Chemother 2009; 53: 2733-9.
9. Carattoli A, Bertini A, Villa L et al. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 2005; 63: 219-28.
10. Carattoli A. Resistance plasmid families in Enterobacteriaceae.Antimicrob Agents Chemother 2009; 53: 2227-38.
11. Osborn AM, da Silvia Tatley FM, Steyn LM et al. Mosaic plasmids and mosaic replicons: evolutionary lessons from the analysis of genetic diversity in IncFII-related replicons. Microbiology 2000; 146: 2267-75.
12. Marcadé G, Deschamps C, Boyd A et al. Replicon typing of plasmids in Escherichia coli producing extended-spectrum b-lactamases.J Antimicrob Chemother 2009; 63: 67-71.
13. Hopkins KL, Liebana E, Villa L et al. Replicon typing of plasmids carrying CTX-M or CMY b-lactamases circulating among Salmonella and Escherichia coli isolates. Antimicrob Agents Chemother 2006; 50:3203-3206.
14. Datta N, Hughes VM. Plasmids of the same Inc groups in enterobacteria before and after the medical use of antibiotics. Nature 1983; 306: 616-7.
15. Kahlmeter G. The ECO.SENS Project: a prospective, multinational,multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens-interim report. J Antimicrob Chemother 2000; 46 Suppl 1: 15-22.
16. Kahlmeter G, Poulsen H. Antimicrobial susceptibility in Escherichia coli from community-acquired urinary tract infections in Europe-the ECO.SENS study revisited. Int J Antimicrob Agents 2011, in press.
17. Swedish Reference Group for Antibiotics. Methods Book-Disk Diffusion. http://www.srga.org/RAFMETOD/rafmet.htm (28 September 2011, date last accessed).
18. Kronvall G, Kahlmeter G, Myhre E et al. A new method for normalized interpretation of antimicrobial resistance from disk test results for comparative purposes. Clin Microbiol Infect 2003; 9:120-32.
19. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000; 66:4555-8.
20. Zhang L, Foxman B, Marrs C. Both urinary and rectal Escherichia coli isolates are dominated by strains of phylogenetic group B2. J Clin Microbiol 2002; 40: 3951-5.
21. Umaer N, Sundsfjord A. The CTX-M conundrum: dissemination of plasmids and Escherichia coli clones. Microb Drug Resist 2011; 17:83-97.
22. Sherley M, Gordon DM, Collignon PJ. Species differences in plasmid carriage in the Enterobacteriaceae. Plasmid 2003; 49: 79-85.
23. Kües U, Stahl U. Replication of plasmids in gram-negative bacteria.Microbiol Rev 1989; 53: 491-516.
24. Villa L, Garcia-Fernández A, Fortini D et al. Replicon sequence typing of IncF plasmids carrying virulence and resistance determinants. J Antimicrob Chemother 2010; 65: 2518-29.
25. Enne VI, Bennett PM, Livermore DM et al. Enhancement of host fitness by the sul2-coding plasmid p9123 in the absence of selective pressure.J Antimicrob Chemother 2004; 53: 958-63.